In Brief: Utah Medical Products/Vital Signs Inc.
This article was originally published in The Gray Sheet
Executive Summary
Utah Medical Products/Vital Signs Inc.: Firms enter agreement under which Vital Signs will market Utah Medical's Deltran IV disposable blood pressure transducer (DPT) in the U.S. Manufactured via an automated process, the Deltran IV is a lower cost version of Utah Medical's hand-assembled Deltran II DPT, which is marketed in the U.S. by Baxter under the name Uniflow. The agreement follows Utah Medical's March announcement that it would seek new marketing partners for the Deltran line due to Baxter's decision to cut back its distribution of the Deltran II and to phase out distribution of Utah Medical's Summit DPT ("The Gray Sheet" March 11, I&W-7). The company notes that it may be nearing another marketing agreement for Deltran IV with a "significant medical monitoring equipment company in the U.S."...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.